[1]

O'Brien JT, Thomas A. 2015. Vascular dementia. The Lancet 386:1698−1706

doi: 10.1016/S0140-6736(15)00463-8
[2]

Wang F, Cao Y, Ma L, Pei H, Rausch WD, et al. 2018. Dysfunction of cerebrovascular endothelial cells: prelude to vascular dementia. Frontiers in Aging Neuroscience 10:376

doi: 10.3389/fnagi.2018.00376
[3]

Ye Q, Won S, Cai D. 2025. Vascular dementia: novel insights through multiscale mechanistic modeling. Signal Transduction and Targeted Therapy 10:351

doi: 10.1038/s41392-025-02433-2
[4]

Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. 2021. Emerging concepts in vascular dementia: a review. Journal of Stroke and Cerebrovascular Diseases 30:105864

doi: 10.1016/j.jstrokecerebrovasdis.2021.105864
[5]

Han B, Jiang W, Liu H, Wang J, Zheng K, et al. 2020. Upregulation of neuronal PGC-1α ameliorates cognitive impairment induced by chronic cerebral hypoperfusion. Theranostics 10:2832−2848

doi: 10.7150/thno.37119
[6]

Du W, Wang J, Zhou L, Zhou J, Feng L, et al. 2023. Transferrin-targeted iridium nanoagglomerates with multi-enzyme activities for cerebral ischemia-reperfusion injury therapy. Acta Biomaterialia 166:524−535

doi: 10.1016/j.actbio.2023.04.025
[7]

Luo Z, Yin F, Wang X, Kong L. 2024. Progress in approved drugs from natural product resources. Chinese Journal of Natural Medicines 22:195−211

doi: 10.1016/S1875-5364(24)60582-0
[8]

Chojdak-Łukasiewicz J, Dziadkowiak E, Zimny A, Paradowski B. 2021. Cerebral small vessel disease: a review. Advances in Clinical and Experimental Medicine 30:349−356

doi: 10.17219/acem/131216
[9]

Dineley KT, Pandya AA, Yakel JL. 2015. Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends in Pharmacological Sciences 36:96−108

doi: 10.1016/j.tips.2014.12.002
[10]

Friedli MJ, Inestrosa NC. 2021. Huperzine A and its neuroprotective molecular signaling in Alzheimer's disease. Molecules 26:6531

doi: 10.3390/molecules26216531
[11]

Xiao W, Su J, Gao X, Yang H, Weng R, et al. 2022. The microbiota-gut-brain axis participates in chronic cerebral hypoperfusion by disrupting the metabolism of short-chain fatty acids. Microbiome 10:62

doi: 10.1186/s40168-022-01255-6
[12]

Xing C, Lv J, Zhu Z, Cong W, Bian H, et al. 2023. Regulation of microglia related neuroinflammation contributes to the protective effect of Gelsevirine on ischemic stroke. Frontiers in Immunology 14:1164278

doi: 10.3389/fimmu.2023.1164278
[13]

Wang J, Zhang Y, Wu H, Yu S, Cai X, et al. 2026. Predicting cerebral acetylcholine dynamics with huperzine A pharmacokinetics in blood via mPBPK-PD modeling. Chinese Journal of Natural Medicines 24:349−364

doi: 10.1016/S1875-5364(26)61109-0
[14]

Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi S. 2010. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66:896−907

doi: 10.1016/j.neuron.2010.05.011
[15]

Kravitz AV, Kreitzer AC. 2012. Striatal mechanisms underlying movement, reinforcement, and punishment. Physiology 27:167−177

doi: 10.1152/physiol.00004.2012
[16]

Lee D, Seo H, Jung MW. 2012. Neural basis of reinforcement learning and decision making. Annual Review of Neuroscience 35:287−308

doi: 10.1146/annurev-neuro-062111-150512
[17]

Jin X, Tecuapetla F, Costa RM. 2014. Basal ganglia subcircuits distinctively encode the parsing and concatenation of action sequences. Nature Neuroscience 17:423−430

doi: 10.1038/nn.3632
[18]

Bormann D, Knoflach M, Poreba E, Riedl CJ, Testa G, et al. 2024. Single-nucleus RNA sequencing reveals glial cell type-specific responses to ischemic stroke in male rodents. Nature Communications 15:6232

doi: 10.1038/s41467-024-50465-z
[19]

Kreitzer AC, Malenka RC. 2008. Striatal plasticity and basal ganglia circuit function. Neuron 60:543−554

doi: 10.1016/j.neuron.2008.11.005
[20]

English DF, Ibanez-Sandoval O, Stark E, Tecuapetla F, Buzsáki G, et al. 2011. GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons. Nature Neuroscience 15:123−130

doi: 10.1038/nn.2984
[21]

Nelson AB, Hammack N, Yang CF, Shah NM, Seal RP, et al. 2014. Striatal cholinergic interneurons drive GABA release from dopamine terminals. Neuron 82:63−70

doi: 10.1016/j.neuron.2014.01.023
[22]

Cheng Y, Huang CCY, Ma T, Wei X, Wang X, et al. 2017. Distinct synaptic strengthening of the striatal direct and indirect pathways drives alcohol consumption. Biological Psychiatry 81:918−929

doi: 10.1016/j.biopsych.2016.05.016
[23]

Gerfen CR, Surmeier DJ. 2011. Modulation of striatal projection systems by dopamine. Annual Review of Neuroscience 34:441−466

doi: 10.1146/annurev-neuro-061010-113641
[24]

Valjent E, Gangarossa G. 2021. The tail of the striatum: from anatomy to connectivity and function. Trends in Neurosciences 44:203−214

doi: 10.1016/j.tins.2020.10.016
[25]

Si J, Chen X, Qi K, Li D, Liu B, et al. 2024. Shengmaisan combined with Liuwei Dihuang Decoction alleviates chronic intermittent hypoxia-induced cognitive impairment by activating the EPO/EPOR/JAK2 signaling pathway. Chinese Journal of Natural Medicines 22:426−440

doi: 10.1016/S1875-5364(24)60640-0
[26]

Yang W, Wen W, Chen H, Zhang H, Lu Y, et al. 2025. Zhongfeng Xingnao Liquid ameliorates post-stroke cognitive impairment through sirtuin1 (SIRT1)/nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway. Chinese Journal of Natural Medicines 23:77−89

doi: 10.1016/S1875-5364(25)60808-9
[27]

Khadka B, Lee JY, Park DH, Kim KT, Bae JS. 2020. The role of natural compounds and their nanocarriers in the treatment of CNS inflammation. Biomolecules 10:1401

doi: 10.3390/biom10101401
[28]

Tomas-Hernandez S, Blanco J, Garcia-Vallvé S, Pujadas G, Ojeda-Montes MJ, et al. 2021. Anti-inflammatory and immunomodulatory effects of the Grifola frondosa natural compound o-orsellinaldehyde on LPS-challenged murine primary glial cells. Roles of NF-κB and MAPK. Pharmaceutics 13:806

doi: 10.3390/pharmaceutics13060806
[29]

Yuan C, Shin M, Park Y, Choi B, Jang S, et al. 2021. Linalool alleviates Aβ42-induced neurodegeneration via suppressing ROS production and inflammation in fly and rat models of Alzheimer's disease. Oxidative Medicine and Cellular Longevity 2021:8887716

doi: 10.1155/2021/8887716
[30]

Dallanoce C. 2022. Recent advances in the modulation of cholinergic signaling. Molecules 27:5971

doi: 10.3390/molecules27185971
[31]

Lee CH, Hung SY. 2023. Physiologic functions and therapeutic applications of α7 nicotinic acetylcholine receptor in brain disorders. Pharmaceutics 15:31

doi: 10.3390/pharmaceutics15010031
[32]

Cai Y, Mok VCT, Markus HS. 2026. Vascular dementia: World Stroke Organization fact sheet 2026. International Journal of Stroke 21:152−63

doi: 10.1177/17474930251404243
[33]

Tian M, Kawaguchi R, Shen Y, Machnicki M, Villegas NG, et al. 2025. Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications. Cell 188:5157−5174.e20

doi: 10.1016/j.cell.2025.06.002
[34]

Kim JS, Chen MH, Wang HE, Lu CL, Wang YP, et al. 2023. Inflammatory bowel disease and neurodegenerative diseases. Gut and Liver 17:495−504

doi: 10.5009/gnl220523
[35]

Tang Y, Yan Y, Mao J, Ni J, Qing H. 2023. The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease. Ageing Research Reviews 86:101865

doi: 10.1016/j.arr.2023.101865
[36]

Xiong B, Zhang W, Zhang L, Huang X, Zhou W, et al. 2020. Hippocampal glutamatergic synapses impairment mediated novel-object recognition dysfunction in rats with neuropathic pain. Pain 161:1824−1836

doi: 10.1097/j.pain.0000000000001878